2027 年欧洲肾脏疾病市场预测 - COVID-19 影响和按产品划分的区域分析(诊断和治疗);最终用户(医院、诊断实验室等);和国家

Historic Data: 2017-2018   |   Base Year: 2019   |   Forecast Period: 2020-2027


No. of Pages: 157    |    Report Code: TIPRE00016073    |    Category: Life Sciences

Europe Kidney Disease Market

市场介绍

肾脏病又称肾病。这是由于肾脏功能失调引起的。肾脏疾病有多种类型,包括肾结石、肾小球肾炎、尿路感染等。为了治疗和诊断这些类型的疾病,不同的全球和地区参与者正在提供各种产品和服务。

 

市场概况和动态< /u>

欧洲肾脏疾病市场预计将从 2019 年的 231.215 亿美元增至 2027 年的 373.111 亿美元。预计从 2020 年开始,该市场将以 6.2% 的复合年增长率增长 - 2027 年。由于慢性肾病发病率增加和政府在医疗保健领域支出的增长等关键驱动因素,预计该市场的增长将会增长。然而,由于缺乏对肾脏疾病的认识,预计市场在预测期内增长缓慢。

主要细分市场

从产品来看,肾病市场细分为诊断和治疗。诊断部分进一步细分为血液检查、尿液检查、影像检查等。治疗部分进一步细分为透析、药物类别等。该药物类别细分为 ACE 抑制剂、血管紧张素 2 受体阻滞剂、利尿剂等。根据最终用户,肾脏疾病市场分为医院、诊断实验室等。

 

主要来源和上市公司

报告中包含的一些主要的肾脏疾病市场主要来源包括欧洲肾脏健康联盟 (EKHA)、英国肾脏护理、国家健康检查调查(意大利) 和其他

 

购买报告的理由

  • 了解欧洲肾脏疾病市场格局并确定最有可能保证丰厚回报的细分市场
  • 保持领先地位了解肾脏疾病市场不断变化的竞争格局
  • 通过识别最有前景的可能销售的细分市场,有效规划欧洲肾脏疾病市场的并购和合作交易
  • 对肾脏疾病市场各个细分市场的市场表现进行敏锐而全面的分析,有助于做出明智的业务决策
  • 获取各个细分市场的市场收入预测2019年至2027年欧洲地区

 

欧洲肾病市场细分

< p> 

按产品

·         诊断

o      血液测试

o      尿液测试

o     成像测试

o      其他

·        治疗

o      透析

o      其他

o      药物类别

§   ACE抑制剂

§   血管紧张素-II 受体阻滞剂

§   利尿剂

§   其他

 

最终用户

·     ;     医院

·         诊断实验室

·        其他

 

按国家/地区

·          欧洲

o      德国

o      英国

o      法国

o      西班牙

o      意大利

公司简介

  • 雅培
  • F.霍夫曼-拉罗氏有限公司
  • 艾伯维公司
  • 辉瑞公司
  • 梯瓦制药工业有限公司
  • 辉瑞公司
  • 梯瓦制药工业有限公司
  • li>
  • 葛兰素史克公司
  • 安进公司
  • 希森美康公司
  • 西门子股份公司
 

Europe Kidney Disease Strategic Insights

Strategic insights for Europe Kidney Disease involve closely monitoring industry trends, consumer behaviours, and competitor actions to identify opportunities for growth. By leveraging data analytics, businesses can anticipate market shifts and make informed decisions that align with evolving customer needs. Understanding these dynamics helps companies adjust their strategies proactively, enhance customer engagement, and strengthen their competitive edge. Building strong relationships with stakeholders and staying agile in response to changes ensures long-term success in any market.

strategic-framework/europe-kidney-disease-market-strategic-framework.webp
Get more information on this report

Europe Kidney Disease Report Scope

Report Attribute Details
Market size in 2019 US$ 23,121.5 Million
Market Size by 2027 US$ 37,311.1 Million
Global CAGR (2020 - 2027) 6.2%
Historical Data 2017-2018
Forecast period 2020-2027
Segments Covered By 产品
  • 诊断和治疗
By 最终用户
  • 医院
  • 诊断实验室
Regions and Countries Covered 欧洲
  • 英国
  • 德国
  • 法国
  • 俄罗斯
  • 意大利
  • 欧洲其他地区
Market leaders and key company profiles
  • Abbott
  • F. Hoffmann-La Roche Ltd
  • AbbVieInc
  • Pfizer Inc
  • Teva Pharmaceutical Industries Ltd
  • GlaxoSmithKline plc
  • Amgen Inc
  • Sysmex Corporation
  • Siemens AG
  • Get more information on this report

    Europe Kidney Disease Regional Insights

    The regional scope of Europe Kidney Disease refers to the geographical area in which a business operates and competes. Understanding regional nuances, such as local consumer preferences, economic conditions, and regulatory environments, is crucial for tailoring strategies to specific markets. Businesses can expand their reach by identifying underserved regions or adapting their offerings to meet regional demands. A clear regional focus allows for more effective resource allocation, targeted marketing, and better positioning against local competitors, ultimately driving growth in those specific areas.

    geography/europe-kidney-disease-market-geography.webp
    Get more information on this report

    The List of Companies - Europe Kidney Disease Market

    The List of Companies - Europe Kidney Disease Market

    1. Abbott
    2. F. Hoffmann-La Roche Ltd
    3. AbbVieInc
    4. Pfizer Inc
    5. Teva Pharmaceutical Industries Ltd
    6. GlaxoSmithKline plc
    7. Amgen Inc
    8. Sysmex Corporation
    9. Siemens AG
    Frequently Asked Questions
    How big is the Europe Kidney Disease Market?

    The Europe Kidney Disease Market is valued at US$ 23,121.5 Million in 2019, it is projected to reach US$ 37,311.1 Million by 2027.

    What is the CAGR for Europe Kidney Disease Market by (2020 - 2027)?

    As per our report Europe Kidney Disease Market, the market size is valued at US$ 23,121.5 Million in 2019, projecting it to reach US$ 37,311.1 Million by 2027. This translates to a CAGR of approximately 6.2% during the forecast period.

    What segments are covered in this report?

    The Europe Kidney Disease Market report typically cover these key segments-

  • 产品 (诊断和治疗)
  • 最终用户 (医院, 诊断实验室)
  • What is the historic period, base year, and forecast period taken for Europe Kidney Disease Market?

    The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the Europe Kidney Disease Market report:

  • Historic Period : 2017-2018
  • Base Year : 2019
  • Forecast Period : 2020-2027
  • Who are the major players in Europe Kidney Disease Market?

    The Europe Kidney Disease Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include:

  • Abbott
  • F. Hoffmann-La Roche Ltd
  • AbbVieInc
  • Pfizer Inc
  • Teva Pharmaceutical Industries Ltd
  • GlaxoSmithKline plc
  • Amgen Inc
  • Sysmex Corporation
  • Siemens AG
  • Who should buy this report?

    The Europe Kidney Disease Market report is valuable for diverse stakeholders, including:

    • Investors: Provides insights for investment decisions pertaining to market growth, companies, or industry insights. Helps assess market attractiveness and potential returns.
    • Industry Players: Offers competitive intelligence, market sizing, and trend analysis to inform strategic planning, product development, and sales strategies.
    • Suppliers and Manufacturers: Helps understand market demand for components, materials, and services related to concerned industry.
    • Researchers and Consultants: Provides data and analysis for academic research, consulting projects, and market studies.
    • Financial Institutions: Helps assess risks and opportunities associated with financing or investing in the concerned market.

    Essentially, anyone involved in or considering involvement in the Europe Kidney Disease Market value chain can benefit from the information contained in a comprehensive market report.